Drug intelligence / Profile preview

hepar-p

Development stage
Phase 2
Lead developer
Nova Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

Hepar-P is a standardized herbal capsule formulation containing 250 mg of Phyllanthus niruri extract (EPN 797) per capsule, standardized to contain 4% corilagin and 18% total flavonoids. It is developed as a natural liver tonic agent, primarily indicated for liver health, including the management of hepatitis B and non-alcoholic fatty liver disease (NAFLD). The mechanism of action is attributed mainly to corilagin and other tannins in Phyllanthus niruri, which have demonstrated antiviral properties by binding virus particles and hepatoprotective effects through antioxidant activity. Clinical studies suggest safety at doses up to 3,000 mg/day for one year; efficacy has been observed in reducing elevated liver enzymes and improving markers of fibrosis in NAFLD patients[1][6][8]. Hepar-P holds two Malaysian patents.

Brand names
Hepar-P
Other names
Phyllanthus niruri

Beyond the preview

Go deeper on hepar-p.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hepar-p.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call